The Small-Cell Lung Cancer market reached a value of USD 8.9 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 23.0 Billion by 2035, exhibiting a growth rate (CAGR) of 9.17% ...

John Ryan, a U.S. Navy veteran, beat cancer through nearly a decade of experimental immunotherapy treatment. The vet shared ...

Columbus Regional Health has the ability to screen for lung cancer and identify it in early stages. Timely identification and diagnosis of lung cancer is the key to long-term survival. Sometimes, ...

Lung cancer survival rates can be as high as 98% for certain cancers diagnosed in an early stage, and as low as 4% for those diagnosed with more aggressive cancers in advanced stages. Survival rates ...

Lung cancer is one of the most common, most dangerous, and most frequently talked about forms of cancer in the world. Of all ...

The Global Cancer Immunotherapy Market achieved a valuation of $121.2 Billion in 2023 and is anticipated to exceed $245.37 ...

The treatment landscape for HER2-positive NSCLC is rapidly evolving as research continues to reveal the genetic drivers of these tumors. Emerging therapies like Pyrotinib (Jiangsu HengRui Medicine), ...

New Screening Device Shows Promise for Early Lung Cancer Detection Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way ...

In lung cancer treatment, a lobectomy is a surgical procedure in which one of the five lobes of the lungs is removed. This intervention can be successful in treating the disease, especially ...

Lung cancer poses a larger threat to the veteran ... Ryan’s CT scans revealed a 65% reduction in tumor size, he told Fox News Digital. "The 65% shrink was great and then that just kind of ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

Despite new paradigm-shifting treatments, lung cancer remains a deadly disease – and improving outcomes requires more than just drug research. The new Lung Ambition Alliance – launched in July ...